Metlife Inc. buy Morgan Stanley
Summary
This prediction ended on 11.07.25 with a price of €66.61. During the runtime of the prediction for Metlife Inc. the price only changed by 0.71%. Morgan_Stanley has a follow-up prediction for Metlife Inc. where he still thinks Metlife Inc. is a Buy. Dividends of €1.53 are taken into consideration when calculating the performance. Morgan_Stanley has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Metlife Inc. | -1.604% | -1.604% | -10.604% |
| iShares Core DAX® | -0.693% | 2.676% | 25.406% |
| iShares Nasdaq 100 | -1.173% | 2.362% | 13.043% |
| iShares Nikkei 225® | -1.388% | 3.465% | 8.037% |
| iShares S&P 500 | -1.411% | 1.137% | 7.803% |
Comments by Morgan_Stanley for this prediction
In the thread Metlife Inc. diskutieren
In the thread Trading Metlife Inc.